<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01710410</url>
  </required_header>
  <id_info>
    <org_study_id>016-2015</org_study_id>
    <nct_id>NCT01710410</nct_id>
  </id_info>
  <brief_title>Transcranial Direct Current Stimulation in a Smoking Cessation Trial</brief_title>
  <acronym>tDCS</acronym>
  <official_title>Pilot Study of Transcranial Direct Current Stimulation (tDCS) as a Smoking Cessation Treatment for Nicotine Dependent Smokers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre for Addiction and Mental Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nuraleve, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre for Addiction and Mental Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effectiveness of transcranial direct current
      stimulation (tDCS) plus nicotine patch as a viable smoking cessation program for nicotine
      dependent smokers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND: Transcranial direct current stimulation (tDCS) is a form of non-invasive brain
      stimulation that involves the application of brief weak electric current to the scalp. tDCS
      may induce neuroplasticity, thereby engaging some of the same systems that figure prominently
      in the pathological neuroplasticity caused by addictive drugs.

      OBJECTIVE: To assess whether tDCS delivered along with nicotine patch reliably increases a)
      quit rates, b) duration of abstinence, and c) percentage of participants abstinent at
      follow-up.

      METHOD: Active (20min; 2mA) and sham (30sec; 2mA) stimulation will be applied to the
      dorsolateral prefrontal cortex (DLPFC) in both cerebral hemispheres.

      HYPOTHESES:

        1. Active tDCS (20-min; 2 mA) will increase abstinence in a standard smoking cessation
           protocol relative to a sham procedure.

        2. The benefits of active left anodal stimulation (anode-left/cathode-right) to the DLPFC
           will be greater than of active tDCS in the reverse configuration
           (cathode-left/anode-right).
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Funding
  </why_stopped>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Smoking Cessation</measure>
    <time_frame>Participants will be followed for the duration of the study, an expected average of 9 months.</time_frame>
    <description>Measure whether active tDCS increases abstinence in a standard smoking cessation protocol relative to a sham tDCS procedure</description>
  </primary_outcome>
  <other_outcome>
    <measure>Smoking cessation rate following transcranial direct current stimulation (tDCS) applied to the left dorsolateral prefrontal cortex (DLPFC) versus the right DLPFC.</measure>
    <time_frame>Participants will be followed for the duration of the study, an expected average of 9 months.</time_frame>
    <description>Measure whether the benefits of active tDCS (anode-left/cathode-right) to the DLPFC will be greater than of active tDCS in the reverse configuration (cathode-left/anode-right) to that region.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Nicotine Dependence</condition>
  <arm_group>
    <arm_group_label>DLPFC tDCS (left anode/right cathode)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active transcranial Direct Current Stimulation (tDCS) administered to the left DLPFC. Brief (20-min) application of weak electric current (e.g., 2 mA) to the scalp.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DLPFC tDCS (left cathode/right anode)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active transcranial Direct Current Stimulation (tDCS) administered to the right DLPFC. Brief (20-min) application of weak electric current (e.g., 2 mA) to the scalp.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DLPFC tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham transcranial Direct Current Stimulation (tDCS) delivered to the DLPFC. Brief (30-sec) application of weak electric current (e.g., 2mA) to the scalp.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>active transcranial Direct Current Stimulation</intervention_name>
    <description>Brief (20-min) application of weak electric current (e.g., 2 mA) to the scalp.</description>
    <arm_group_label>DLPFC tDCS (left anode/right cathode)</arm_group_label>
    <arm_group_label>DLPFC tDCS (left cathode/right anode)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham transcranial Direct Current Stimulation</intervention_name>
    <description>Brief (30-sec) application of weak electric current (e.g., 2mA) to the scalp.</description>
    <arm_group_label>DLPFC tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  nicotine dependent

          -  treatment-seeking

          -  smoke minimum of 15 cigarettes per day

          -  able to provide written informed consent

          -  able and willing to attend weekly appointments, inter-treatment and follow-up
             assessment

          -  able and willing to wear nicotine patch

        Exclusion Criteria:

          -  currently taking GABA receptor agonists, NMDA receptor antagonists, dopamine receptor
             agonists/antagonists, SSRIs, L-dopa, anticholinergics

          -  pregnancy or lactation

          -  any serious medical condition requiring treatment or medication including high blood
             pressure, heart problems, asthma, epilepsy

          -  brain/neurological injury/disease/disorder

          -  skin disease

          -  current DSM-IV Axis I psychiatric disorder

          -  metal or medical device implants

          -  current treatment for alcohol or drug use

          -  current use of herbal/holistic preparations

          -  current use of recreational drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurie Zawertailo, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Addiction and Mental Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre for Addiction and Mental Health (Nicotine Dependence Clinic)</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 1P5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.camh.ca</url>
    <description>Centre for Addiction and Mental Health (investigator-driven, not initiated, study)</description>
  </link>
  <link>
    <url>http://www.braininstitute.ca/</url>
    <description>Ontario Brain Institute</description>
  </link>
  <link>
    <url>http://www.nuraleve.com</url>
    <description>Nuraleve, Inc. (regulatory sponsor with Health Canada)</description>
  </link>
  <reference>
    <citation>Boggio PS, Liguori P, Sultani N, Rezende L, Fecteau S, Fregni F. Cumulative priming effects of cortical stimulation on smoking cue-induced craving. Neurosci Lett. 2009 Sep 29;463(1):82-6. doi: 10.1016/j.neulet.2009.07.041. Epub 2009 Jul 18.</citation>
    <PMID>19619607</PMID>
  </reference>
  <reference>
    <citation>Feil J, Zangen A. Brain stimulation in the study and treatment of addiction. Neurosci Biobehav Rev. 2010 Mar;34(4):559-74. doi: 10.1016/j.neubiorev.2009.11.006. Epub 2009 Nov 13. Review.</citation>
    <PMID>19914283</PMID>
  </reference>
  <reference>
    <citation>Fregni F, Liguori P, Fecteau S, Nitsche MA, Pascual-Leone A, Boggio PS. Cortical stimulation of the prefrontal cortex with transcranial direct current stimulation reduces cue-provoked smoking craving: a randomized, sham-controlled study. J Clin Psychiatry. 2008 Jan;69(1):32-40.</citation>
    <PMID>18312035</PMID>
  </reference>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2012</study_first_submitted>
  <study_first_submitted_qc>October 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2012</study_first_posted>
  <last_update_submitted>June 9, 2016</last_update_submitted>
  <last_update_submitted_qc>June 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre for Addiction and Mental Health</investigator_affiliation>
    <investigator_full_name>Laurie Zawertailo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>transcranial direct current stimulation</keyword>
  <keyword>nicotine dependence</keyword>
  <keyword>dorsolateral prefrontal cortex</keyword>
  <keyword>nicotine replacement therapy</keyword>
  <keyword>nicotine patch</keyword>
  <keyword>addiction</keyword>
  <keyword>smoking cessation</keyword>
  <keyword>neuroplasticity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

